Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dozile
- Development stage
- Unknown
- Lead developer
- Key Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Dozile is an over-the-counter (OTC) consumer healthcare product developed and supplied by Key Pharmaceuticals for the temporary relief of insomnia and sleeplessness. Its active ingredient is doxylamine succinate, a first-generation antihistamine that acts as an inverse agonist at the histamine H1 receptor. By crossing the blood-brain barrier and antagonizing H1 receptors in the central nervous system, it exerts a sedative effect. In Australia, Dozile is registered under AUST R 143861 and is classified as a Schedule 3 Pharmacist Only Medicine. It is available in both tablet and capsule formulations, typically containing 25 mg of the active ingredient.
- Brand names
- Dozile
- Other names
- doxylamine succinate
02
Targets
mAChR (Muscarinic acetylcholine receptors)KCNH2 (Voltage-gated potassium channel subfamily H member 2)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Dozile.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dozile.